Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: A PC1/3 hypermorph

Endocrinology (United States)

Volumn 155, Issue 9, 2014, Pages 3434-3447

  Blanco, Elias H ^a   Peinado, Juan R ^a   Martín, Martín G ^b   Lindberg, Iris ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CALCIUM; COCAINE; PROOPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; GLYCINE; SERINE;

ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OBESITY; PH; PROTEIN CLEAVAGE; WILD TYPE; AMINO ACID SEQUENCE; CHEMISTRY; ENZYME STABILITY; GENETICS; KINETICS; METABOLISM; MISSENSE MUTATION; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ENZYME STABILITY; GLYCINE; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROPROTEIN CONVERTASE 1; PROTEIN STRUCTURE, TERTIARY; SERINE;

EID: 84907059375     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-2151     Document Type: Article

References (61)

1. Kenny PJ. Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci. 2011;12:638-651.
2. Rholam M, Fahy C. Processing of peptide and hormone precursors at the dibasic cleavage sites. Cell Mol Life Sci. 2009;66:2075-2091.
3. Wardman JH, Zhang X, Gagnon S, et al. Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative pep-tidomics. J Neurochem. 2010;114:215-225.
4. Creemers JW, Choquet H, Stijnen P, et al. Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes. 2012;61:383-390.
5. Benzinou M, Creemers JW, Choquet H, et al. Common nonsynony-mous variants in PCSK1 confer risk of obesity. Nat Genet. 2008; 40:943-945.
6. Gjesing AP, Vestmar MA, Jorgensen T, et al. The effect of PCSK1 variants on waist, waist-hip ratio and glucose metabolism is modified by sex and glucose tolerance status. PLoS One. 2011;6:e23907.
7. Lloyd DJ, Bohan S, Gekakis N. Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. Hum Mol Genet. 2006; 15:1884-1893.
8. Bandsma RH, Sokollik C, Chami R, et al. From diarrhea to obesity in prohormone convertase 1/3 deficiency: age-dependent clinical, pathologic, and enteroendocrine characteristics. J Clin Gastroen-terol. 2013;47:834-843.
9. Martin MG, Lindberg I, Solorzano-Vargas RS, et al. Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathiesin apediatric cohort. Gastroenterology. 2013;145:138-148.
10. Dillon SL, Williamson DM, Elferich J, et al. Propeptides are sufficient to regulate organelle-specific pH-dependent activation of furin and proprotein convertase 1/3. J Mol Biol. 2012;423:47-62.
11. Schmidt WK, Moore H-PH. Ionic milieu controls the compartment-specific activation of pro-opiomelanocortin processing in AtT-20 cells. Mol Biol Cell. 1995;6:1271-1285.
12. Lindberg I. Evidence for cleavageofthe PC1/PC3 pro-segmentinthe endoplasmic reticulum. Mol Cell Neurosci. 1994;5:263-268.
13. Zhou A, Mains RE. Endoproteolytic processing of proopiomelano-cortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. J Biol Chem. 1994; 269:17440-17447.
14. Zhou Y, Lindberg I. Enzymatic properties of carboxyl-terminally truncated prohormone convertase 1 (PC1/SPC3) and evidence for autocatalytic conversion. J Biol Chem. 1994;269:18408-18413.
15. Zhou Y, Rovere C, Kitabgi P, Lindberg I. Mutational analysis of PC1 (SPC3) in PC12 cells. 66-kDa PC1 is fully functional. J Biol Chem. 1995;270:24702-24706.
16. Seidah NG, Marcinkiewicz M, Benjannet S, et al. Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, Furin, and Kex2: distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2. Mol Endocrinol. 1991;5:111-122.
17. Seidah NG, Hamelin J, Gaspar AM, Day R, Chretien M. The cDNA sequence of the human pro-hormone and pro-protein convertase PC1. DNA Cell Biol. 1992;11:283-289.
18. Hoshino A, Lindberg I. Peptide biosynthesis: prohormone convertases 1/3 and 2. In: Fricker LD, Devi L, eds. Morgan, Claypool Life Sciences Publishers; 2012.
19. Creemers JW, Roebroek AJ, Van de Ven WJ. Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3. Cloning and primary sequence of a 5 kb cDNA. FEBS Lett. 1992; 300:82-88.
20. Pickett LA, Yourshaw M, Albornoz V, et al. Functional consequences of a novel variant of PCSK1. PLoS One. 2013;8:e55065.
21. Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947-2948.
22. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 1997;16:303-306.
23. Jackson RS, Creemers JW, Farooqi IS, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human pro-protein convertase 1 deficiency. J Clin Invest. 2003;112:1550-1560.
24. Farooqi IS, Volders K, Stanhope R, et al. Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. J Clin Endocrinol Metab. 2007;92:3369-3373.
25. Philippe J, Stijnen P, Meyre D, et al. A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity [published online June 3, 2014]. Int J Obes (Lond). doi: 10.1038/ijo.2014.96.
26. Blanco EH, Lagos CF, Andres ME, Gysling K. Anamphipathic a-he-lix in the prodomain of cocaine and amphetamine regulated transcript peptide precursor serves as its sorting signal to the regulated secretory pathway. PLoS One. 2013;8:e59695.
27. Vindrola O, Lindberg I. Biosynthesis of the prohormone convertase mPC1 in AtT-20 cells. Mol Endocrinol. 1992;6:1088-1094.
28. Shen FS, Seidah NG, Lindberg I. Biosynthesis of the prohormone convertase PC2 in Chinese hamster ovary cells and in rat insulinoma cells. J Biol Chem. 1993;268:24910-24915.
29. Muller L, Cameron A, Fortenberry Y, Apletalina EV, Lindberg I. Processing and sorting of the prohormone convertase 2 propeptide. J Biol Chem. 2000;275:39213-39222.
30. Helwig M, Lee SN, Hwang JR, Ozawa A, Medrano JF, Lindberg I. Dynamic modulation of PC2-mediated precursor processing by 7B2: preferential effect on glucagon synthesis. J Biol Chem. 2011; 286:42504-42513.
31. Dhillo WS, Gardiner JV, Castle L, et al. Agouti related protein (AgRP) is upregulated in Cushing's syndrome. Exp Clin Endocrinol Diabetes. 2005;113:602-606.
32. Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962;194: 495-496.
33. Henrich S, Lindberg I, Bode W, Than ME. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. J Mol Biol. 2005;345:211-227.
34. Henrich S, Cameron A, Bourenkov GP, et al. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat Struct Biol. 2003;10:520-526.
35. Apletalina E, Appel J, Lamango NS, Houghten RA, Lindberg I. Identification of inhibitors of prohormone convertases 1 and 2 using a peptide combinatorial library. J Biol Chem. 1998;273:26589-26595.
36. Dey A, Xhu X, Carroll R, Turck CW, Stein J, Steiner DF. Biological processing of the cocaine and amphetamine-regulated transcript precursors by prohormone convertases, PC2 and PC1/3. J Biol Chem. 2003;278:15007-15014.
37. Benjannet S, Rondeau N, Day R, Chretien M, Seidah NG. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA. 1991;88:3564-3568.
38. Mbikay M, Sirois F, Nkongolo KK, Basak A, Chretien M. Effects of rs6234/rs6235 and rs6232/rs6234/rs6235 PCSK1 single-nucleotide polymorphism clusters on proprotein convertase 1/3 biosynthesis and activity. Mol Genet Metab. 2011;104:682-687.
39. Rouille Y, Westermark G, Martin SK, Steiner DF. Proglucagon is processed to glucagon by prohormone convertase PC2 in aTC1-6 cells. Proc Natl Acad Sci USA. 1994;91:3242-3246.
40. Rouille Y, Martin S, Steiner DF. Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide. J Biol Chem. 1995;270:26488-26496.
41. Zhou Y, Lindberg I. Purification and characterization of the prohormone convertase PC1(PC3). J Biol Chem. 1993;268:5615-5623.
42. Benjannet S, Reudelhuber T, Mercure C, Rondeau N, Chretien M, Seidah NG. Proprotein conversion is determined by a multiplicity of factors including convertase processing, substrate specificity, and intracellular environment. Cell type-specific processing of human prorenin by the convertase PC1. J Biol Chem. 1992;267:11417-11423.
43. Icimoto MY, Barros NM, Ferreira JC, et al. Hysteretic behavior of proprotein convertase 1/3 (PC1/3). PLoS One. 2011;6:e24545.
44. Ozawa A, Peinado JR, Lindberg I. Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis. Endocrinology. 2010;151:4437-4445.
45. Hutton JC. The internal pH and membrane potential of the insulin-secretory granule. Biochem J. 1982;204:171-178.
46. Bulenda D, Gratzl M. Matrix free Ca2+ in isolated chromaffin vesicles. Biochemistry. 1985;24:7760-7765.
47. Fricker LD, McKinzie AA, Sun J, et al. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci. 2000;20: 639-648.
48. Cameron A, Fortenberry Y, Lindberg I. The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1. FEBS Lett. 2000;473:135-138.
49. Lee SN, Prodhomme E, Lindberg I. Prohormone convertase 1 (PC1) processing and sorting: effect of PC1 propeptide and proSAAS. J Endocrinol. 2004;182:353-364.
50. Zhou A, Paquet L, Mains RE. Structural elements that direct specific processing of different mammalian subtilisin-like prohormone convertases. J Biol Chem. 1995;270:21509-21516.
51. Lacombe MJ, Mercure C, Dikeakos JD, Reudelhuber TL. Modulation of secretory granule-targeting efficiency by cis and trans compounding of sorting signals. J Biol Chem. 2005;280:4803-4807.
52. Dikeakos JD, Lacombe MJ, Mercure C, Mireuta M, Reudelhuber TL. A hydrophobic patch in a charged a-helix is sufficient to target proteins to dense core secretory granules. J Biol Chem. 2007;282: 1136-1143.
53. Dikeakos JD, Di Lello P, Lacombe MJ, et al. Functional and structural characterization of a dense core secretory granule sorting domain from the PC1/3 protease. Proc Natl Acad Sci USA. 2009;106: 7408-7413.
54. Rabah N, Gauthier D, Dikeakos JD, Reudelhuber TL, Lazure C. The C-terminal region of the proprotein convertase 1/3 (PC1/3) exerts a bimodal regulation of the enzyme activity in vitro. FEBS J. 2007; 274:3482-3491.
55. Zhou A, Bloomquist BT, Mains RE. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem. 1993;268:1763-1769.
56. Ugleholdt R, Poulsen ML, Holst PJ, et al. Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulino-tropic polypeptide precursor. J Biol Chem. 2006;281:11050-11057.
57. Yaswen L, Diehl N, Brennan M, Hochgeschwender U. Obesity in the mouse model of pro-opimelanocortin deficiency responds to peripheral melanocortin. Nat Med. 1999;5:1066-1070.
58. Kajiwara H, Itoh Y, Itoh J, Yasuda M, Osamura RY. Immunohis-tochemical expressions of prohormone convertase (PC)1/3 and PC2 in carcinoids of various organs. Tokai J Exp Clin Med. 1999;24: 13-20.
59. Mbikay M, Sirois F, Yao J, Seidah NG, Chretien M. Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 inhuman lung tumours. Br J Cancer. 1997;75:1509-1514.
60. North WG, Du J. Key peptide processing enzymes are expressed by a variant form of small-cell carcinoma of the lung. Peptides. 1998; 19:1743-1747.
61. Hashemzadeh S, Asvadi Kermani A, Ali-Asgharzadeh A, Halimi M, Soleimani M, Ladan A. Ectopic Cushing's syndrome secondary to pulmonary carcinoid tumor. Ann Thorac Surg. 2013;95:1797-1799.